Obesity and hypertensive heart disease: focus on body composition and sex differences

Giovanni de Simone1, Costantino Mancusi1, Raffaele Izzo1

  • 1Hypertension Research Center, Federico II University Hospital, Via S. Pansini 5, Building 1, 80131 Naples, Italy ; Department of Translational Medical Sciences, Federico II University Hospital, Naples, Italy.

Insights

Obesity and hypertension in youth can lead to harmful left ventricular (LV) hypertrophy (LVH). Body composition, not just blood pressure, significantly impacts LVH development, especially in women.

Area of Science:

  • Cardiology
  • Obesity Research
  • Hypertension Studies

Background:

  • Hypertension and overweight/obesity are common in children and adolescents, both contributing to left ventricular (LV) hypertrophy (LVH).
  • Obesity typically causes eccentric LV geometry (balanced growth), while hypertension is linked to concentric LV geometry (thickened walls).
  • Concentric LV geometry, the most detrimental pattern, becomes more prevalent in obese individuals with age and in obese-hypertensive patients.

Approach:

  • Investigated the influence of body composition and hemodynamic factors on LV geometry in obese-hypertensive individuals.
  • Examined the role of severe obstructive sleep apnea and masked hypertension in developing concentric LV geometry.
  • Analyzed the impact of adipose mass and fat-free mass on LV mass, particularly in women.

Key Points:

  • Concentric LV geometry, a harmful pattern, increases with age in obese individuals and is frequent in obese-hypertensive patients.
  • Non-hemodynamic factors, specifically body composition, play a crucial role in the prevalence of concentric LV geometry.
  • Adipose mass significantly influences LV mass, especially in women with lower fat-free mass.

Conclusions:

  • While blood pressure control is vital for managing LVH in obese hypertensive patients, reducing visceral adiposity is essential for LVH regression.
  • Further research is needed to understand the prognostic implications of body composition-driven LVH versus pressure overload LVH.
  • Future studies should focus on tissue characterization of hypertrophic hearts in obese-hypertensive patients and the utility of hemodynamic/biomarker assessments for management.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
323
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
340
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259